Literature DB >> 22466514

Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.

Kyung Won Doo1, Deuk Jae Sung, Beom Jin Park, Min Ju Kim, Sung Bum Cho, Yu Whan Oh, Young Hwii Ko, Kyung Sook Yang.   

Abstract

OBJECTIVES: To evaluate the incremental value of diffusion-weighted imaging (DWI) in combination with T2-weighted imaging to detect low (Gleason score, ≤ 6) and intermediate or high risk (Gleason score, ≥ 7) prostate cancer.
METHODS: Fifty-one patients who underwent MRI before prostatectomy were evaluated. Two readers independently scored the probability of tumour in eight regions of prostate on T2-weighted images (T2WI) and T2WI combined with apparent diffusion coefficient (ADC) maps. Data were divided into two groups--low risk and intermediate or high risk prostate cancer--and correlated with histopathological results. Diagnostic performance parameters, areas under the receiver-operating characteristic curve (AUCs) and interreader agreement were calculated.
RESULTS: For both readers, AUCs of combined T2WI and ADC maps were greater than those of T2WI in intermediate or high risk (reader 1, 0.887 vs. 0.859; reader 2, 0.732 vs 0.662, P < 0.05) prostate cancers, but not in low risk (reader 1, 0.719 vs 0.725; reader 2, 0.685 vs. 0.680, P > 0.05) prostate cancers. Weighted κ value of combined T2WI and ADC maps was 0.689.
CONCLUSIONS: The addition of DWI to T2-weighted imaging improves the accuracy of detecting intermediate or high risk prostate cancers, but not for low risk prostate cancer detection. KEY POINTS: • Gleason scores influence diagnostic performance of MRI for prostate cancer detection. • Addition of DWI does not improve low risk prostate cancer detection. • Combined T2WI and DWI may help select intermediate or high risk patients.

Entities:  

Mesh:

Year:  2012        PMID: 22466514     DOI: 10.1007/s00330-012-2430-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation.

Authors:  Kazuhiro Katahira; Taro Takahara; Thomas C Kwee; Seitaro Oda; Yasuko Suzuki; Shoji Morishita; Kosuke Kitani; Yasuyuki Hamada; Mitsuhiko Kitaoka; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2010-07-18       Impact factor: 5.315

Review 2.  Diffusion weighted imaging in prostate cancer.

Authors:  Cher Heng Tan; Jihong Wang; Vikas Kundra
Journal:  Eur Radiol       Date:  2010-10-09       Impact factor: 5.315

3.  Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?

Authors:  Yasushi Itou; Katsuyuki Nakanishi; Yoshifumi Narumi; Yasuko Nishizawa; Hideaki Tsukuma
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

4.  Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules.

Authors:  N M desouza; S A Reinsberg; E D Scurr; J M Brewster; G S Payne
Journal:  Br J Radiol       Date:  2007-02-15       Impact factor: 3.039

5.  Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence.

Authors:  Niall M Corcoran; Matthew K H Hong; Rowan G Casey; Antonio Hurtado-Coll; Justin Peters; Laurence Harewood; S Larry Goldenberg; Chris M Hovens; Anthony J Costello; Martin E Gleave
Journal:  BJU Int       Date:  2011-03-28       Impact factor: 5.588

6.  Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.

Authors:  Aytekin Oto; Cheng Yang; Arda Kayhan; Maria Tretiakova; Tatjana Antic; Christine Schmid-Tannwald; Scott Eggener; Gregory S Karczmar; Walter M Stadler
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

7.  Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.

Authors:  Leonardo Kayat Bittencourt; Jelle O Barentsz; Luiz Carlos Duarte de Miranda; Emerson Leandro Gasparetto
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

8.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

Authors:  Baris Turkbey; Vijay P Shah; Yuxi Pang; Marcelino Bernardo; Sheng Xu; Jochen Kruecker; Julia Locklin; Angelo A Baccala; Ardeshir R Rastinehad; Maria J Merino; Joanna H Shih; Bradford J Wood; Peter A Pinto; Peter L Choyke
Journal:  Radiology       Date:  2010-12-21       Impact factor: 11.105

9.  Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.

Authors:  Courtney A Woodfield; Glenn A Tung; David J Grand; John A Pezzullo; Jason T Machan; Joseph F Renzulli
Journal:  AJR Am J Roentgenol       Date:  2010-04       Impact factor: 3.959

Review 10.  Imaging prostate cancer: a multidisciplinary perspective.

Authors:  Hedvig Hricak; Peter L Choyke; Steven C Eberhardt; Steven A Leibel; Peter T Scardino
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

View more
  13 in total

1.  Usefulness of 3T diffusion-weighted MRI for discrimination of reactive and metastatic cervical lymph nodes in patients with oral squamous cell carcinoma: a pilot study.

Authors:  J Si; S Huang; H Shi; Z Liu; Q Hu; G Wang; G Shen; D Zhang
Journal:  Dentomaxillofac Radiol       Date:  2014-01-22       Impact factor: 2.419

2.  Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients.

Authors:  Tae Heon Kim; Chan Kyo Kim; Byung Kwan Park; Hwang Gyun Jeon; Byung Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Seong Soo Jeon
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

3.  Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.

Authors:  Tae Heon Kim; Jae Yong Jeong; Sin Woo Lee; Chan Kyo Kim; Byung Kwan Park; Hyun Hwan Sung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Seong Soo Jeon
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

Review 4.  Diffusion-weighted imaging in prostate cancer.

Authors:  Tsutomu Tamada; Yu Ueda; Yoshiko Ueno; Yuichi Kojima; Ayumu Kido; Akira Yamamoto
Journal:  MAGMA       Date:  2021-09-07       Impact factor: 2.533

Review 5.  Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer.

Authors:  Seyed Saeid Dianat; H Ballentine Carter; Katarzyna J Macura
Journal:  Urol Oncol       Date:  2013-06-17       Impact factor: 3.498

6.  Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens.

Authors:  Kosuke Kitamura; Satoru Muto; Isao Yokota; Kazutane Hoshimoto; Tatsuro Kaminaga; Takahiro Noguchi; Syou-Ichiro Sugiura; Hisamitsu Ide; Raizo Yamaguchi; Shigeru Furui; Shigeo Horie
Journal:  Prostate Int       Date:  2014-12-30

7.  Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.

Authors:  Jie Bao; Ximing Wang; Chunhong Hu; Jianquan Hou; Fenglin Dong; Lingchuan Guo
Journal:  Eur J Radiol Open       Date:  2017-09-29

8.  Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.

Authors:  Liuhui Zhang; Donggen Jiang; Chujie Chen; Xiangwei Yang; Hanqi Lei; Zhuang Kang; Hai Huang; Jun Pang
Journal:  Br J Radiol       Date:  2021-09-29       Impact factor: 3.039

9.  High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness.

Authors:  Tsutomu Tamada; Naoki Kanomata; Teruki Sone; Yoshimasa Jo; Yoshiyuki Miyaji; Hiroki Higashi; Akira Yamamoto; Katsuyoshi Ito
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

10.  Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient - a systematic review and meta analysis.

Authors:  Hans-Jonas Meyer; Andreas Wienke; Alexey Surov
Journal:  BMC Cancer       Date:  2020-05-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.